Jazz Pharmaceuticals
JAZZ
#2116
Rank
S$10.01 B
Marketcap
$165.64
Share price
-1.17%
Change (1 day)
4.58%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): S$0.52 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$3.99 Billion. In 2023 the company made an earning of S$0.40 Billion, an increase over its 2022 earnings that were of -S$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.52 B28.52%
2023 S$0.40 B-179.92%
2022 -S$0.51 Billion230.37%
2021 -S$0.16 Billion-141.02%
2020 S$0.37 B-39.45%
2019 S$0.62 B-14.2%
2018 S$0.72 B20.03%
2017 S$0.60 B-17.15%
2016 S$0.72 B22.14%
2015 S$0.59 B187.64%
2014 S$0.20 B-50.79%
2013 S$0.42 B73.63%
2012 S$0.24 B41.69%
2011 S$0.17 B116.61%
2010 S$78.99 M262.77%
2009 S$21.77 M-111.33%
2008 -S$0.2 Billion1.31%
2007 -S$0.19 Billion77.8%
2006 -S$0.11 Billion36.59%
2005 -S$78.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$3.27 Billion-699.99%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$2.86 B 425.95%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.40 B 3,093.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$0.57 B 5.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel